33 related articles for article (PubMed ID: 8078011)
1. A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Yoneda A; Shichino H; Hishiki T; Matsumoto K; Ohira M; Kamijo T; Kuroda T; Soejima T; Nakazawa A; Takimoto T; Yokota I; Teramukai S; Takahashi H; Fukushima T; Hara J; Kaneko M; Ikeda H; Tajiri T; Mugishima H; Nakagawara A
Pediatr Blood Cancer; 2024 Jun; 71(6):e30976. PubMed ID: 38577760
[TBL] [Abstract][Full Text] [Related]
2. Two hits are better than one: rational dual strategy efficiently fights neuroblastoma.
Zimmer J; Rolin C; Ollert M
Signal Transduct Target Ther; 2024 Apr; 9(1):116. PubMed ID: 38688910
[No Abstract] [Full Text] [Related]
3. Platinum-induced hearing loss after treatment for childhood cancer.
van As JW; van den Berg H; van Dalen EC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906
[TBL] [Abstract][Full Text] [Related]
4. Analysis of AC3-33 gene expression in multiple organ cancer and adjacent normal tissue by RNA
Hu F; Yang S; Lv S; Peng Y; Meng L; Gou L; Zhang X
Oncol Lett; 2015 Jun; 9(6):2795-2798. PubMed ID: 26137149
[TBL] [Abstract][Full Text] [Related]
5. Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.
Wang M; Zhou C; Cai R; Li Y; Gong L
Diagn Pathol; 2013 Jan; 8():5. PubMed ID: 23320395
[TBL] [Abstract][Full Text] [Related]
6. Experience with International Neuroblastoma Staging System and Pathology Classification.
Ikeda H; Iehara T; Tsuchida Y; Kaneko M; Hata J; Naito H; Iwafuchi M; Ohnuma N; Mugishima H; Toyoda Y; Hamazaki M; Mimaya J; Kondo S; Kawa K; Okada A; Hiyama E; Suita S; Takamatsu H
Br J Cancer; 2002 Apr; 86(7):1110-6. PubMed ID: 11953858
[TBL] [Abstract][Full Text] [Related]
7. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
Chan EL; Harris RE; Emery KH; Gelfand MJ; Collins MH; Gruppo RA
Pediatr Blood Cancer; 2007 Apr; 48(4):479-82. PubMed ID: 16333837
[TBL] [Abstract][Full Text] [Related]
8. N-myc oncogene and stage IV-S neuroblastoma. Preliminary observations on ten cases.
Nakagawara A; Sasazuki T; Akiyama H; Kawakami K; Kuwano A; Yokoyama T; Kume K
Cancer; 1990 May; 65(9):1960-7. PubMed ID: 2196987
[TBL] [Abstract][Full Text] [Related]
9. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma.
Iwafuchi M; Utsumi J; Tsuchida Y; Kaneko M; Matsuyama S; Ohnuma N; Taguchi N; Mugishima H; Yokoyama J; Sasaki S; Yoshioka A; Nagahara N; Fukuzawa M; Suita S
Med Pediatr Oncol; 1996 Dec; 27(6):515-20. PubMed ID: 8888810
[TBL] [Abstract][Full Text] [Related]
11. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification.
Kaneko M; Tsuchida Y; Mugishima H; Ohnuma N; Yamamoto K; Kawa K; Iwafuchi M; Sawada T; Suita S
J Pediatr Hematol Oncol; 2002 Nov; 24(8):613-21. PubMed ID: 12439032
[TBL] [Abstract][Full Text] [Related]
12. Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan.
Kaneko M; Nishihira H; Mugishima H; Ohnuma N; Nakada K; Kawa K; Fukuzawa M; Suita S; Sera Y; Tsuchida Y
Med Pediatr Oncol; 1998 Jul; 31(1):1-7. PubMed ID: 9607422
[TBL] [Abstract][Full Text] [Related]
13. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma.
Kaneko M; Tsuchida Y; Uchino J; Takeda T; Iwafuchi M; Ohnuma N; Mugishima H; Yokoyama J; Nishihira H; Nakada K; Sasaki S; Sawada T; Kawa K; Nagahara N; Suita S; Sawaguchi S
J Pediatr Hematol Oncol; 1999; 21(3):190-7. PubMed ID: 10363851
[TBL] [Abstract][Full Text] [Related]
14. What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese Study Group for the Treatment of Advanced Neuroblastoma.
Suita S; Zaizen Y; Kaneko M; Uchino J; Takeda T; Iwafuchi M; Utsumi J; Takahashi H; Yokoyama J; Nishihira H
J Pediatr Surg; 1994 Jun; 29(6):746-50. PubMed ID: 8078011
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
